Wharton’s Jelly Injections

Wharton’s Jelly injections have the ability to develop — through a process called differentiation — into many different types of cells, such as cartilage, tendons, ligaments, etc. Wharton’s Jelly is a key component of regenerative medicine, as they open the door to new clinical applications.

Wharton’s Jelly treatment takes advantage of the body’s ability to repair itself. With Wharton’s Jelly injection therapy, our medical staff injects Wharton’s Jelly from amniotic tissues into your body. Wharton’s Jelly injections have anti-inflammatory properties, similar to cortisone and steroid shots. However, this type of therapy goes far beyond the benefits of standard “injection therapy.”

While cortisone and other drugs only provide temporary pain relief and over time can cause degeneration of soft tissues, Wharton’s Jelly injections actually restore degenerated tissue while providing pain relief. The growth factors in Wharton’s Jelly may replace damaged cells in your body. Additionally, injections contain hyaluronic acid, which lubricates joints and tendons, easing the pain and helping restore mobility.

• Wharton’s Jelly injections contain no steroids. Instead, the injections rely on naturally occurring anti-inflammatory agents, such as cytokines.
• Wharton’s Jelly injections contain hyaluronic acid, which lubricates cartilage and promotes new cartilage growth.
• Wharton’s Jelly injections contain growth factors, which stimulate tissue growth.
• With Wharton’s Jelly injections, there is no threat of patient rejection.

YES!

• Wharton’s Jelly injections are a preferred type of therapy because the cells come from an immunoprivileged site, which means that patient-rejection is extremely rare.
• The use of Wharton’s Jelly injections are well researched, safe, and effective.
• All donors go through a rigorous screening process, as determined by the Food and Drug Administration (FDA) and American Association of Tissue Banks (AATB).

Initial Visit
An initial consultation with our medical team will be required to find out if you are a candidate for Wharton’s Jelly injections. If you are determined to be a candidate for Wharton’s Jelly injections your procedure will be scheduled for another day. This initial consultation is usually covered by your insurance plan.

Preparation
For two weeks prior to your procedure, do not take aspirin or anti-inflammatory medications (NSAIDS).

Procedure
Stand alone Wharton’s Jelly injections are done as an outpatient procedure, so most patients will leave the clinic and resume low impact activities the same day. Some patients have reported mild pain for 48-72 hours after their procedure, but this can often be attributed to the absence of their routine anti-inflammatory medications. After this time period, most patients will experience a gradual decrease in pain and some may begin to notice increased function.

Post-Procedure
To give your procedure the best chance to provide lasting results, our medical team recommends the following post-procedure restrictions:

• Do not take anti-inflammatory medication for 2 weeks after your procedure.
• Rest for the first 24-48 hours after your procedure.
• Restrict the treated joint to low impact / general use for the first 2 weeks.
• For weeks 3-4, you may resume walking, cardio, and light lifting.
• After 4 weeks, you may resume running and weightlifting.
• Pay special attention to the treated joint and contact your physician with any questions or concerns you may have.

* Please Note:
If you are having Wharton’s Jelly injections procedure in conjunction with another surgical procedure, your recommendations may change. Consult with your physician on the guidelines and restrictions for your specific case.

No. Because injections are considered investigational for orthopedic applications, most insurance companies will not cover the cost. Please contact our office to discuss cash payment options.

Patients suffering from any kind of joint, tendon, or ligament pain may be considered as candidates for Wharton’s Jelly injections at Axe Holistic Medicine. In some cases, patients with severe degenerative osteoarthritis may not be eligible for Wharton’s Jelly injections.